Despite the focus on high drug prices, orphan drugs are expected to grow at double the rate of the rest of the pharmaceutical industry over the next six years. Orphan drug sales are set to grow 11% each year between now and 2024, compared with 6.4% growth for the overall pharma market in the same period, according to a report from EvaluatePharma.
